Literature DB >> 11214912

A transgenic model of a familial prion disease.

D A Harris1, R Chiesa, B Drisaldi, E Quaglio, A Migheli, P Piccardo, B Ghetti.   

Abstract

We have generated lines of transgenic mice that express a mutant prion protein containing 14 octapeptide repeats whose human homologue is associated with an inherited prion dementia. These mice develop an ataxic illness that begins at 65 days of age when the transgene array is homozygous, and results in death by 115-138 days. Starting from birth, mutant PrP is converted into a protease-resistant and detergent-insoluble form that resembles PrP(Sc), and this form accumulates dramatically in many brain regions throughout the lifetime of the mice. As PrP accumulates, there is massive apoptosis of cerebellar granule cells, as well as astrocytosis and deposition of PrP in a punctate pattern. These results establish a new transgenic animal model of an inherited human prion disease, and provide important insights into the molecular pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214912     DOI: 10.1007/978-3-7091-6308-5_9

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  2 in total

1.  Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease.

Authors:  Yael Friedman-Levi; Zeev Meiner; Tamar Canello; Kati Frid; Gabor G Kovacs; Herbert Budka; Dana Avrahami; Ruth Gabizon
Journal:  PLoS Pathog       Date:  2011-11-03       Impact factor: 6.823

2.  PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease.

Authors:  Yael Friedman-Levi; Michal Mizrahi; Kati Frid; Orli Binyamin; Ruth Gabizon
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.